Tyra Biosciences, Inc. (TYRA)
33.11
-0.48
(-1.43%)
USD |
NASDAQ |
May 27, 15:48
Tyra Biosciences Cash from Investing (Quarterly) : -120.24M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 56.58M |
| Relay Therapeutics, Inc. | 32.90M |
| Tango Therapeutics, Inc. | 9.635M |
| Entrada Therapeutics, Inc. | 26.99M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.57M |
| Cash from Financing (Quarterly) | 160.38M |
| Free Cash Flow | -102.47M |
| Free Cash Flow Per Share (Quarterly) | -0.5289 |
| Free Cash Flow to Equity (Quarterly) | -32.55M |
| Free Cash Flow to Firm (Quarterly) | -32.66M |
| Free Cash Flow Yield | -5.14% |